Kimberly K. Laubmeier, PhD
- 2Articles
- 6.7KReads1
- 2012Active
- 7Collaborators
- 2Citations2
About
Kimberly K. Laubmeier, PhD, has published research focused on the treatment of major depressive disorder (MDD), particularly examining the efficacy of adjunctive aripiprazole. Her work includes analyses of clinical trials assessing aripiprazole's benefits independent of antidepressant therapy history and its early response predictive value. She has contributed to studies related to schizophrenia and schizoaffective disorders as well.
Publications
Beneficial Effects of Adjunctive Aripiprazole in Major Depressive Disorder Are Not Dependent on Antidepressant Therapy History: A Post Hoc Analysis of 3 Randomized, Double-Blind, Placebo-Controlled Trials
November 22, 2012
Efficacy of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Response Quartile Analysis and the Predictive Value of Week 2 Early Response
May 31, 2012
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
